zur Startseite
HomeHow to find usPrivacy PolicyImprint
Clinical Intergroup
Pathology Panel
Research
Clinical Trials
Members
News/Publications

iNNOVATE Follow-up data on efficacy and safety of ibrutinib in treatment naïve and relapsed patients with WM orally presented at this year’s ASH in San Diego

read more ›
 

IWWM10 - New York - 2018

We thank Steven Treon and his team for organizing the fantastic IWWM10 in New York in October this year. A great meeting and motivation for all of us to continue our efforts to improve treatment of WM
 
Show all news/publications ›

Clinical Intergroup

Clinical Intergroup

 

The ECWM is based on a clinical intergroup connecting all major clinical national study groups such as:

  • BNLI
  • Czech Myeloma Group
  • FIL Italian Intergroup
  • FCGCLLWM Group
  • GLA/OSHO
  • Greek Myeloma Study Group 
  • HOVON 
  • Nordic Lymphoma Group
  • Portuguese Lymphoma Study Group
  • Spanish Study Group 

The ECWM is associated with the Australasian Leukaemia & Lymphoma Goup (ALLG). This clinical intergroup forms a unique platform for setting up large clinical and innovative trials in a rare disease such as WM.

 

Currently several clinical trials are initiated which offer patients with WM novel therapeutic approaches in the setting of well controlled clinical trials.